Northland Securities reiterated their sell rating on shares of Intuitive Surgical (NASDAQ:ISRG) in a research report sent to investors on Thursday morning. The brokerage currently has a $375.00 price target on the medical equipment provider’s stock.
“We are tweaking our models accordingly, and are introducing our FY20 numbers. Key Points Instrument & Accessory revs @ $539M vs. our estimate @ $535M. Systems revs @ $340M vs. our estimate @ $327M.”,” Northland Securities’ analyst wrote.
Several other analysts also recently issued reports on ISRG. Zacks Investment Research raised shares of Intuitive Surgical from a hold rating to a buy rating and set a $541.00 target price on the stock in a research note on Thursday. Piper Jaffray Companies boosted their target price on shares of Intuitive Surgical to $613.00 and gave the company an overweight rating in a research note on Friday, October 19th. ValuEngine downgraded shares of Intuitive Surgical from a hold rating to a sell rating in a research note on Friday, December 7th. Canaccord Genuity raised shares of Intuitive Surgical from a hold rating to a buy rating and upped their price target for the stock from $550.00 to $610.00 in a research note on Friday, October 19th. They noted that the move was a valuation call. Finally, Raymond James upped their price target on shares of Intuitive Surgical from $620.00 to $630.00 and gave the stock an outperform rating in a research note on Friday, October 19th. One research analyst has rated the stock with a sell rating, four have given a hold rating and seventeen have issued a buy rating to the stock. The stock currently has a consensus rating of Buy and a consensus price target of $563.17.
Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 18th. The medical equipment provider reported $2.83 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.66 by $0.17. The business had revenue of $920.90 million during the quarter, compared to the consensus estimate of $916.22 million. Intuitive Surgical had a return on equity of 18.79% and a net margin of 22.31%. The business’s revenue was up 14.0% on a year-over-year basis. During the same period in the previous year, the firm posted $2.77 earnings per share. As a group, equities research analysts forecast that Intuitive Surgical will post 9.54 earnings per share for the current year.
In other news, EVP David J. Rosa sold 32,500 shares of Intuitive Surgical stock in a transaction on Tuesday, October 23rd. The shares were sold at an average price of $500.86, for a total transaction of $16,277,950.00. Following the transaction, the executive vice president now directly owns 44,208 shares of the company’s stock, valued at $22,142,018.88. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Lonnie M. Smith sold 225 shares of Intuitive Surgical stock in a transaction on Wednesday, November 7th. The stock was sold at an average price of $540.04, for a total transaction of $121,509.00. Following the transaction, the director now directly owns 379,175 shares in the company, valued at $204,769,667. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 72,491 shares of company stock valued at $37,767,784. Company insiders own 2.20% of the company’s stock.
Hedge funds and other institutional investors have recently made changes to their positions in the company. Moody National Bank Trust Division acquired a new stake in Intuitive Surgical in the 4th quarter valued at $38,000. Cornerstone Advisors Inc. boosted its holdings in shares of Intuitive Surgical by 32.3% during the 3rd quarter. Cornerstone Advisors Inc. now owns 123 shares of the medical equipment provider’s stock worth $71,000 after buying an additional 30 shares during the period. Arrow Financial Corp bought a new stake in shares of Intuitive Surgical during the 3rd quarter worth about $115,000. JNBA Financial Advisors bought a new stake in shares of Intuitive Surgical during the 3rd quarter worth about $115,000. Finally, Pendal Group Ltd bought a new stake in shares of Intuitive Surgical during the 3rd quarter worth about $118,000. 84.14% of the stock is currently owned by institutional investors.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Featured Article: 52-Week High/Low Prices For Stock Selection
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.